0000905148-23-001027.txt : 20230928 0000905148-23-001027.hdr.sgml : 20230928 20230928163206 ACCESSION NUMBER: 0000905148-23-001027 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20230926 FILED AS OF DATE: 20230928 DATE AS OF CHANGE: 20230928 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: CPMG Inc CENTRAL INDEX KEY: 0001372218 STATE OF INCORPORATION: TX FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-37785 FILM NUMBER: 231290196 BUSINESS ADDRESS: STREET 1: 4215 WEST LOVERS LANE STREET 2: SUITE 100 CITY: DALLAS STATE: TX ZIP: 75209 BUSINESS PHONE: 214-871-6816 MAIL ADDRESS: STREET 1: 4215 WEST LOVERS LANE STREET 2: SUITE 100 CITY: DALLAS STATE: TX ZIP: 75209 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Desai Antal Rohit CENTRAL INDEX KEY: 0001881616 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-37785 FILM NUMBER: 231290197 MAIL ADDRESS: STREET 1: C/O PROCEPT BIOROBOTICS CORPORATION STREET 2: 900 ISLAND DRIVE CITY: REDWOOD CITY STATE: CA ZIP: 94065 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: REATA PHARMACEUTICALS INC CENTRAL INDEX KEY: 0001358762 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 113651945 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 5320 LEGACY DRIVE CITY: PLANO STATE: TX ZIP: 75024 BUSINESS PHONE: 972-865-2219 MAIL ADDRESS: STREET 1: 5320 LEGACY DRIVE CITY: PLANO STATE: TX ZIP: 75024 4 1 form4.xml X0508 4 2023-09-26 true 0001358762 REATA PHARMACEUTICALS INC RETA 0001881616 Desai Antal Rohit 4215 WEST LOVERS LN., STE 100 DALLAS TX 75209 true true 0001372218 CPMG Inc 4215 WEST LOVERS LN., STE 100 DALLAS TX 75209 true true false Class A common stock 2023-09-26 4 D 0 31467 D 0 I By The 2:22 DNA Trust Class A common stock 2023-09-26 4 D 0 113 D 0 I By CPMG, Inc. Class A common stock 2023-09-26 4 D 0 116512 D 0 I By Nighthawk Partners, LP Class A common stock 2023-09-26 4 D 0 282246 D 0 I By Willet Fund, LP Class A common stock 2023-09-26 4 D 0 137962 D 0 I By Killdeer Fund, LP Class A common stock 2023-09-26 4 D 0 5464 D 0 I By Elepaio Partners, LP Class A common stock 2023-09-26 4 D 0 44200 D 0 I By Barred Owl Partners, LP Class A common stock 2023-09-26 4 D 0 34897 D 0 I By Managed Account for Trustees of the University of Pennsylvania Class A common stock 2023-09-26 4 D 0 442560 D 0 I By Gallopavo, LP Class A common stock 2023-09-26 4 D 0 748253 D 0 I By Roadrunner Fund, LP Class A common stock 2023-09-26 4 D 0 431155 D 0 I By Yellow Warbler, LP Class A common stock 2023-09-26 4 D 0 109415 D 0 I By Mallard Fund, LP Class A common stock 2023-09-26 4 D 0 37909 D 0 I By Crested Crane, LP Class A common stock 2023-09-26 4 D 0 334740 D 0 I By Sandpiper Fund, LP Class A common stock 2023-09-26 4 D 0 160265 D 0 I By Kestrel Fund, LP( Class A common stock 2023-09-26 4 D 0 11076 D 0 I By CD Fund, LP Class A common stock 2023-09-26 4 D 0 134 D 0 I By Redbird Life Sciences Partners, LP Class B common stock 2023-09-26 4 D 0 1251 D Class A common stock 1251 0 I By CPMG, Inc. Class B common stock 2023-09-26 4 D 0 150186 D Class A common stock 150186 0 I By Mallard Fund, LP Class B common stock 2023-09-26 4 D 0 307776 D Class A common stock 307776 0 I By Kestrel Fund, LP Class B common stock 2023-09-26 4 D 0 123279 D Class A common stock 123279 0 I By CD Fund, LP Class B common stock 2023-09-26 4 D 0 1490 D Class A common stock 1490 0 I By Redbird Life Sciences Partners, LP Class B common stock 2023-09-26 4 D 0 114946 D Class A common stock 114946 0 I By Willet Fund, LP Class B common stock 2023-09-26 4 D 0 993929 D Class A common stock 993929 0 I By Yellow Warbler, LP Mr. Desai and his spouse serve as co-trustees of The 2:22 DNA Trust. CPMG, Inc. is the investment manager of each of: Nighthawk Partners, LP; Barred Owl Partners, LP; Killdeer Fund, LP; Crested Crane, LP; Gallopavo, LP; Roadrunner Fund, LP; Sandpiper Fund, LP; Mallard Fund, LP; Yellow Warbler, LP; Kestrel Fund, LP; Willet Fund, LP; Elepaio Partners, LP; CD Fund, LP; Redbird Life Sciences Partners, LP.; a managed account for Trustees of the University of Pennsylvania (collectively, the "Funds"). In such capacity, CPMG, Inc. may be deemed to have voting and investment power over the securities held directly by each of the Funds. Kent McGaughy, Jr. and Antal Desai, each of whom is a shareholder and managing partner of CPMG, Inc., may be deemed to share voting and investment power with respect to the securities held directly by CPMG, Inc. and the Funds. Mr. McGaughy, Jr. reports his beneficial ownership of these securities on a separate Form 4. Each of CPMG, Inc. and Mr. Desai (collectively, the "Reporting Persons") disclaims beneficial ownership of the securities reported herein except to the extent of its and his pecuniary interest therein, if any, and this report shall not be deemed an admission that the Reporting Persons are the beneficial owners of such securities for purposes of Section 16 of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), or for any other purpose. Pursuant to the Agreement and Plan of Merger, dated July 28, 2023, by and among the Issuer, Biogen Inc. ("Biogen") and River Acquisition, Inc., the Issuer became a wholly-owned subsidiary of Biogen upon consummation of the merger (the "Effective Time"). At the Effective Time, each of the Issuer's outstanding shares of Class A common stock and Class B common stock was canceled and extinguished and automatically converted into the right to receive $172.50 in cash, without interest, less any withholding taxes. The Class B common stock was convertible into Class A common stock on a one-for-one basis at the holder's election at any time. The conversion right of the Class B common stock had no expiration date. Mr. McGaughy, Jr. serves on the Issuer's Board of Directors (the "Board") as a representative of CPMG, Inc. By virtue of his representation on the Board, for purposes of Section 16 of the Exchange Act, the Reporting Persons may be deemed to be directors of the Issuer by deputization of Mr. McGaughy, Jr. /s/ Antal Rohit Desai 2023-09-28 /s/ John Bateman, Chief Operating Officer of CPMG, Inc. 2023-09-28